You are here

Nurosene Health Inc.

Nurosene Health Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
MEND
CSE Index: 
Currency: 

Nurosene is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of Nurosene Health Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit www.nurosene.com.

 

You are here

Nurosene Health Inc. (MEND)

SEDAR Information

Company Info

Address
101-1655 Dupont Street
Toronto, ON M6P 3T1
Canada
Phone
403-681-2549
Email
swapan@nurosene.com
Website
http://www.nurosene.com/
Listing date
Monday, June 7, 2021
Transfer Agent
Odyssey Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
42,206,225
Reserved for Issuance: 
4,928,784

Company Officers

George Achilleos, Chief Executive Officer

Bulletins

03/06/2021

2021-0609 – New Listing - Nurosene Health Inc. (MEND)

Le 3 juin/June 2021

The common shares of Nurosene Health Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-10-03-Xplor-Mining-Convention-2022_Website.png

Xplor 2022 - Mining Convention

Monday, October 3, 2022 - 9:00am to Thursday, October 6, 2022 - 7:30pm